Skip to main content
. 2021 Mar 29;19(6):986–997. doi: 10.1016/j.gpb.2020.05.006

Table 4.

Interactions between kinase inhibitors and MHC class I proteins (HLA alleles)

Drug Best docking score No. of structures showing favorable binding (out of 33)
Sorafenib −149.75 13
Sunitinib −199.22 31
Imatinib −126.73 15
Dasatinib −188.48 18
Pazopanib −157.97 2